Envestnet Asset Management
PMVP icon

Envestnet Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Envestnet Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,872
Closed -$269K – 3740
2021
Q2 		$269K Buy
+7,872
New +$263K ﹤0.01% 3350
2021
Q1 		– Sell
-5,529
Closed -$340K – 3559
2020
Q4 		$340K Buy
+5,529
New +$217K ﹤0.01% 2866

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Envestnet Asset Management's PMVP Position: Q3 2021 in Review

Envestnet Asset Management sold out of PMV Pharmaceuticals (PMVP) in Q3 2021, closing a stake of 7,872 shares — an estimated $269K sold.

Envestnet Asset Management first reported a position in PMVP in Q4 2020 and held it in 2 quarters. The position peaked at $340K in Q4 2020. 92 funds tracked by Wall St. Rank hold PMVP as of Q3 2021.

  • Envestnet Asset Management reported no remaining PMV Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 7,872 PMV Pharmaceuticals shares in Q3 2021, an estimated $269K.
  • Envestnet Asset Management first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Envestnet Asset Management's PMV Pharmaceuticals position peaked at $340K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2021.

Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.